Table 2. Summary of CT clinical studies with relative correlations with EAT and others adipose tissue compartments.
Authors | AI category | Algorithm and/or software | Adipose tissue compartments | Data | Correlation | Number of patients | Results | Level of evidence* |
---|---|---|---|---|---|---|---|---|
Kroll et al. [2021] (46) | Deep learning | U-Net 3D | EAT | EAT Volume | Calcium artery score | 966 | r=0.18 | 3 |
Paracardialadipose tissue | EAT Attenuation | r=−0.09 | ||||||
Visceral adipose tissue | ||||||||
Intermuscularadipose tissue | ||||||||
Subcutaneous adipose tissue | ||||||||
Eisenberg et al. [2020] (47) | Deep learning | Fully automated DL algorithm incorporated into QFAT research software (version 2.0) | EAT | EAT Volume | Major adverse cardiovascular events | 2,068 | P<0.01 | 1 |
EAT Attenuation | P=0.01 | |||||||
Oikonomouet al. [2019] (48) | Machine learning | Aquarius Workstation V.4.4.11-13, TeraRecon Inc., Foster City, CA, USA for basic segmentation and CaRi-HEART proprietary algorithms | Perivascular adipose tissue | Fat attenuation index | Inflammation | 167, 1,575, 44 | See Figure 4 for inflammation, vascularity and fibrosis | 1, 3, 3 |
Caristo Diagnostics Ltd, Oxford, UK | Fat radiomic profile | Vascularity | ||||||
Slicer Radiomics extension which incorporates the Pyradiomics library into 3D Slicer (v.4.9.0-2017-12-18 r26813) | Fibrosis | |||||||
Major adverse cardiovascular events | P<0.001 | |||||||
Perivascular changes related to acute myocardial infarction | P<0.001 | |||||||
Lin et al. [2021] (49) | Deep learning | QFAT v2.0, CSMC, Los Angeles, CA, USA | EAT | EAT volume | Major adverse cardiovascular events | 2,068 | P<0.001 | 2 |
NAFLD | EAT attenuation | P<0.001 | ||||||
Hepatic attenuation | P=0.003 | |||||||
Tamarappooet al. [2021] (50) | Deep learning | QFAT v2.0, CSMC, Los Angeles, CA, USA | EAT | EAT volume | Long-term risk prediction for cardiac events | 1,069 | P<0.0001 | 1 |
EAT attenuation | P=0.002 |
*, SIGN100: Scottish Intercollegiate Guidelines Network 2019. CT, computed tomography; AI, artificial intelligence; EAT, epicardial adipose tissue; NAFLD, non-alcoholic fatty liver disease.